Zobrazeno 1 - 10
of 730
pro vyhledávání: '"BERKTAS M"'
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 12, Pp 307-315 (2020)
Mehmet Berktas,1 Feza Kirbiyik,2 Elif Aribal,2 Anil Aksit,2 Derya Ufuk Altintas3 1Blue Idea Consulting, London, UK; 2Nutricia Advanced Medical Nutrition, Istanbul, Turkey; 3Cukurova University Medical School, Allergy and Immunology Department, Adana,
Externí odkaz:
https://doaj.org/article/bd6667650dbc4b6cb5bf38a6408cff1e
Autor:
Drysdale M; Value Evidence and Outcomes, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK. myriam.g.drysdale@gsk.com., Berktas M; Value Evidence and Outcomes, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK., Gibbons DC; Value Evidence and Outcomes, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK., Rolland C; Evidence Synthesis, Modelling and Communications, PPD Evidera, London, UK., Lavoie L; Evidence Synthesis, Modelling and Communications, PPD Evidera, Montreal, Canada., Lloyd EJ; Value Evidence and Outcomes, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK.
Publikováno v:
Infection [Infection] 2024 Oct; Vol. 52 (5), pp. 1839-1861. Date of Electronic Publication: 2024 Apr 11.
Publikováno v:
In Indian Journal of Medical Microbiology April-June 2016 34(2):202-207
Autor:
Muthusamy B; Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, USA., Berktas M; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Li J; Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA., Thomas DS; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Sun P; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Taylor A; Global Oncology Outcome Research, AstraZeneca, Cambridge, UK., Pennell NA; Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH 44195, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (28), pp. 2083-2096. Date of Electronic Publication: 2024 Jun 25.
Publikováno v:
Kafkas Universitesi Veteriner Fakültesi Dergisi, Vol 19, Iss 2, Pp 271-276 (2013)
Externí odkaz:
https://doaj.org/article/f4939ea41e604e5f987ad4cec0e9ab73
Autor:
Ostoros G; National Korányi Institute of Pulmonology, Budapest, Hungary., Hettle R; AstraZeneca, Cambridge, UK., Georgoulia N; AstraZeneca, Gaithersburg, MD, USA., Berktas M; AstraZeneca, Gaithersburg, MD, USA., Chander P; AstraZeneca, Gaithersburg, MD, USA., Diaz Perez I; AstraZeneca, Gaithersburg, MD, USA., Couto AM; Oxford PharmaGenesis, Oxford, UK., Eichinger C; Oxford PharmaGenesis, Oxford, UK., Field P; Oxford PharmaGenesis, Oxford, UK., Morten P; AstraZeneca, Cambridge, UK.
Publikováno v:
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2023 Jul-Dec; Vol. 23 (12), pp. 1305-1313. Date of Electronic Publication: 2023 Dec 08.
Autor:
Christopoulos, P., Girard, N., Zhang, L., Mbanya, Z., Dunton, K., Ali, A., Berktas, M., Delmastro, L., Struebing, A., Xiong, Y., Lay-Flurrie, S., Hindocha, P., Mehdikhanova, T.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S796-S797
Autor:
Debieuvre, D., Macouillard, P., Quantin, X., Berktas, M., Girard, N., Audigier Valette, C., Filleron, T., Musilli, S., Bosquet, L., Pérol, M.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S799-S799
Autor:
Nieva, J., Karia, P.S., Okhuoya, P., Berktas, M., Salomonsen, R.J-B., Servidio, L., Chapaneri, J., De Silva, K., Martin, E., Griesinger, F.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S774-S774